Harmony Biosciences Holdings, Inc. HRMY Enterprise value

Enterprise value at other companies

Jazz PharmaceuticalsJAZZ

$16.37B+47.7%

AlkermesALKS

$9.79B+123%

Axsome TherapeuticsAXSM

$8.56B+52.9%

Stoke Therapeutics, Inc.STOK

$1.77B+1,855%

Amneal Pharmaceuticals, Inc.AMRX

$7.97B+71.3%

Acadia PharmaceuticalsACAD

$4.02B+13.2%

FAQ

What is Harmony Biosciences Holdings, Inc.'s enterprise value?

Harmony Biosciences Holdings, Inc. (HRMY) reported enterprise value of $1.2B in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s enterprise value changed year-over-year?

Harmony Biosciences Holdings, Inc.'s enterprise value decreased by 24.9% year-over-year, from $1.59B to $1.2B.

What is the long-term trend for Harmony Biosciences Holdings, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s enterprise value has grown at a -4.9% compound annual growth rate (CAGR), from $2.02B to $1.57B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.